Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges
The oral mucosa offers an attractive route for the systemic delivery of drugs. The bioavailability and effectiveness of many drugs can be increased by administering them through the oral mucosa which bypasses the first-pass metabolism effect. This article will discuss principles, application areas, benefits & drawbacks as well as possible future perspectives for the study and development of oromucosal drug delivery systems. Among the critical benefits of administering drugs via the mouth is that it starts acting fast, is easily absorbed into the bloodstream, makes it easier for patients to follow their prescriptions as well and offers more freedom in terms of dosage control. The article emphasizes innovative technologies such as nanoparticulate formulations as well as microfabricated devices which are slated to improve drug targeting and delivery. It also touches on such related issues as taste masking, variability in bioavailability, and regulatory concerns.
-
romucosal Drug Delivery, Bioavailability, Patient Compliance, Drug Targeting, Safety Considerations, Innovative Technologies, Future Directions
-
(1) Syed Muhammad Talha
Graduate Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
(2) Pakeeza Zainab
Graduate Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
(3) Mamoona Khalid
Graduate Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
(4) Areej Javed
Graduate Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Cite this article
-
APA : Talha, S. M., Zainab, P., & Khalid, M. (2023). Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges. Global Pharmaceutical Sciences Review, VIII(IV), 37-48. https://doi.org/10.31703/gpsr.2023(VIII-IV).04
-
CHICAGO : Talha, Syed Muhammad, Pakeeza Zainab, and Mamoona Khalid. 2023. "Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges." Global Pharmaceutical Sciences Review, VIII (IV): 37-48 doi: 10.31703/gpsr.2023(VIII-IV).04
-
HARVARD : TALHA, S. M., ZAINAB, P. & KHALID, M. 2023. Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges. Global Pharmaceutical Sciences Review, VIII, 37-48.
-
MHRA : Talha, Syed Muhammad, Pakeeza Zainab, and Mamoona Khalid. 2023. "Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges." Global Pharmaceutical Sciences Review, VIII: 37-48
-
MLA : Talha, Syed Muhammad, Pakeeza Zainab, and Mamoona Khalid. "Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges." Global Pharmaceutical Sciences Review, VIII.IV (2023): 37-48 Print.
-
OXFORD : Talha, Syed Muhammad, Zainab, Pakeeza, and Khalid, Mamoona (2023), "Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges", Global Pharmaceutical Sciences Review, VIII (IV), 37-48
-
TURABIAN : Talha, Syed Muhammad, Pakeeza Zainab, and Mamoona Khalid. "Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges." Global Pharmaceutical Sciences Review VIII, no. IV (2023): 37-48. https://doi.org/10.31703/gpsr.2023(VIII-IV).04